The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO-Reference-Cited by-同舟云学术

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

Author:

Collins P.¹,Chalmers E.²,Chowdary P.³,Keeling D.⁴,Mathias M.⁵,O'Donnell J.⁶,Pasi K. J.⁷,Rangarajan S.⁸,Thomas A.⁹

Affiliation:

1. Arthur Bloom Haemophilia Centre; University Hospital of Wales; Cardiff UK

2. Haemophilia Centre; Royal Hospital for Sick Children; Glasgow UK

3. Katharine Dormandy Haemophilia Centre; Royal Free Hospital; London UK

4. Haemophilia Centre; Churchill Hospital; Oxford UK

5. Haemophilia Centre; Great Ormond Street Hospital; London UK

6. Haemophilia Centre; St. James Hospital; Dublin Ireland

7. Haemophilia Centre; Royal London Hospital; London UK

8. Haemophilia Centre; Basingstoke and North Hampshire Hospital; Basingstoke UK

9. Haemophilia Centre; Royal Infirmary of Edinburgh; Edinburgh UK

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

Reference50 articles.

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Hämophilie-Behandlung in Österreich;Wiener klinische Wochenschrift;2024-05

3. Modern aspects of hemophilia A diagnosis;Pediatric Hematology/Oncology and Immunopathology;2024-04-18